|
ATP5G3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.495600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.906400E-01 |
| Normal-vs-Stage2 |
4.840800E-01 |
| Normal-vs-Stage3 |
8.556000E-01 |
| Normal-vs-Stage4 |
8.919600E-01 |
| Stage1-vs-Stage2 |
6.626600E-01 |
| Stage1-vs-Stage3 |
6.998200E-01 |
| Stage1-vs-Stage4 |
8.158600E-01 |
| Stage2-vs-Stage3 |
5.358200E-01 |
| Stage2-vs-Stage4 |
5.764200E-01 |
| Stage3-vs-Stage4 |
9.814400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.478010E-01 |
| Normal-vs-AfricanAmerican |
4.549000E-01 |
| Normal-vs-Asian |
8.602400E-01 |
| Caucasian-vs-AfricanAmerican |
1.304380E-01 |
| Caucasian-vs-Asian |
6.187600E-01 |
| AfricanAmerican-vs-Asian |
9.159600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.833800E-02 |
| Normal-vs-Female |
4.321200E-01 |
| Male-vs-Female |
6.252300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.203800E-01 |
| Normal-vs-Extreme_Weight |
3.152400E-01 |
| Normal-vs-Obese |
3.603800E-01 |
| Normal-vs-Extreme_Obese |
2.667600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.511600E-01 |
| Normal_Weight-vs-Obese |
8.574000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.404200E-02 |
| Extreme_Weight-vs-Obese |
8.726000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.878210E-01 |
| Obese-vs-Extreme_Obese |
8.733700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.413800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.467800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.679000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.184400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.924400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.597000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.606600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.058800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.195200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.958800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.573700E-02 |
| Normal-VS-Type2 PRCC |
9.189500E-02 |
| Normal-VS-KIRP CIMP |
1.716600E-03 |
| Normal-VS-Unclassified PRCC |
8.355400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.956540E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.451900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.343800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.562020E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.943430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.611770E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.119000E-01 |
| Normal-vs-N1 |
7.882800E-01 |
| Normal-vs-N2 |
6.243600E-01 |
| N0-vs-N1 |
7.642200E-01 |
| N0-vs-N2 |
6.446000E-01 |
| N1-vs-N2 |
8.616600E-01 |
|
|
